Inventor · disambiguated record
Shih-Chong Tsai
Also filed as: TSAI SHIH-CHONG
6 granted patents·3 pending applications·11 citations·filing 2002–2023
74Inventor score
Top patents by PatentIndex Score
9 records- 0182US9382331B2Alpha-enolase specific antibodies and methods of uses in cancer therapyDEV CENTER BIOTECHNOLOGY·Filed 2013·Granted Jul 5, 2016·5 cites·20 claims
- 0280US11085062B2Processes for preparing glycoprotein-drug conjugatesDEV CT BIOTECHNOLOGY·Filed 2017·Granted Aug 10, 2021·2 cites·36 claims
- 0374US10781266B2Antibodies specific to alpha-enolase and uses thereofDEV CT BIOTECHNOLOGY·Filed 2018·Granted Sep 22, 2020·1 cites·10 claims
- 0471US9527922B2Humanized alpha-enolase specific antibodies and methods of uses in cancer therapyDEV CT BIOTECHNOLOGY·Filed 2014·Granted Dec 27, 2016·2 cites·15 claims
- 0563US9750804B2Alpha-enolase specific antibodies and method of use in immune diseasesDEV CT BIOTECHNOLOGY·Filed 2014·Granted Sep 5, 2017·1 cites·15 claims
- 0663US2024238432A1Method for glycoprotein modificationHONEYBEAR BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 0759US2025197501A1Recombinant antibody, immunoconjugate comprising the same, and uses thereof in treating cancersDEV CT BIOTECHNOLOGY·Filed 2023·Application pending·0 cites
- 0850US11998613B2Antibody-drug conjugates containing an anti-mesothelin antibody and uses thereofDEV CT BIOTECHNOLOGY·Filed 2021·Granted Jun 4, 2024·0 cites·15 claims
- 0943US2003073236A1p193 proteins and nucleic acids, and uses thereofFiled 2002·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →